secwatch.observer — SEC 8-K summary
======================================

Issuer:     TScan Therapeutics, Inc. (TCRX)
CIK:        0001783328
Form:       8-K
Filed at:   2021-07-20T23:59:59+00:00
Accession:  0001193125-21-219696
Event type: other_material
Sentiment:  neutral
Materiality: 0.60
Item codes: 5.02, 5.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

TScan Therapeutics completes IPO; Christoph Westphal resigns from board; charter amended
--------------------------------------------------------------------------------

- Christoph Westphal, M.D., Ph.D. resigned from board effective after IPO pricing; no disagreement with management.
- Amended charter authorizes 300M voting common shares, 10M non-voting common, 10M preferred shares.
- Adopted classified board with staggered three-year terms; directors removable only for cause with 66 2/3% vote.
- Bylaws revised to eliminate stockholder action by written consent and special meetings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1783328/000119312521219696/0001193125-21-219696-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1783328/000119312521219696/d172723d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-21-219696

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer